
Magstim Certifications Mark Growing Acceptance of TMS for Treating Depression
Magstim Horizon Inspire and 3.0 Transcranial Magnetic Stimulation Systems have received FDA clearance for the treatment of major depressive disorder (MDD) in adolescent patients, ages 15-21. Announced in March, the approval adds to other recent […]